CAS 989-61-7

989-61-7 11H,13H-Oxireno(d)pyrano(4',3':3,3a)isobenzofuro(5,4-f)(2)benzopyran-6,13(5aalphaH)-dione, 8alpha-(3-furyl)-2,2aalpha,3,4,4a,8,8a,9,10,10aalpha,14,14aalpha-dodecahydro-4alpha-hydroxy-2,2,4,4abeta,8,8aalpha-tetramethyl- 8alpha-(3-furyl)-2,2aalpha,3,4,4a,8,8a,9,10,10aalpha,14,14aalpha-dodecahydro-4alpha-hydroxy-2,2,4,4abeta,8,8aalpha-tetramethyl-11H,13H-oxireno(d)pyrano(4',3':3,3a)isobenzofuro(5,4-f)(2)benzopyran-6,13(5aalphaH)-dione Liminol

纯度 97%+现货药物标准品
CAS 号989-61-7
分子式C26H32O8
分子量472.53 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

 989-61-7
11H,13H-Oxireno(d)pyrano(4',3':3,3a)isobenzofuro(5,4-f)(2)benzopyran-6,13(5aalphaH)-dione, 8alpha-(3-furyl)-2,2aalpha,3,4,4a,8,8a,9,10,10aalpha,14,14aalpha-dodecahydro-4alpha-hydroxy-2,2,4,4abeta,8,8aalpha-tetramethyl-
8alpha-(3-furyl)-2,2aalpha,3,4,4a,8,8a,9,10,10aalpha,14,14aalpha-dodecahydro-4alpha-hydroxy-2,2,4,4abeta,8,8aalpha-tetramethyl-11H,13H-oxireno(d)pyrano(4',3':3,3a)isobenzofuro(5,4-f)(2)benzopyran-6,13(5aalphaH)-dione
Liminol CAS 989-61-7 结构式 Chemical Structure

产品介绍 Description

(989-61-7 11H,13H-Oxireno(d)pyrano(4',3':3,3a)isobenzofuro(5,4-f)(2)benzopyran-6,13(5aalphaH)-dione, 8alpha-(3-furyl)-2,2aalpha,3,4,4a,8,8a,9,10,10aalpha,14,14aalpha-dodecahydro-4alpha-hydroxy-2,2,4,4abeta,8,8aalpha-tetramethyl- 8alpha-(3-furyl)-2,2aalpha,3,4,4a,8,8a,9,10,10aalpha,14,14aalpha-dodecahydro-4alpha-hydroxy-2,2,4,4abeta,8,8aalpha-tetramethyl-11H,13H-oxireno(d)pyrano(4',3':3,3a)isobenzofuro(5,4-f)(2)benzopyran-6,13(5aalphaH)-dione Liminol,CAS 号 989-61-7)是 CATO 佳途自主生产的药物标准品,分子式 C26H32O8,分子量 472.53。纯度 97%+。本品采用严格的质量控制体系生产,附 COA 证书,适用于药物研发、质量控制和法规申报等场景。

从化学结构特征来看,的分子骨架中包含羧酸类,含羟基,含醚键,多环芳烃。该化合物的不饱和度为11.0,表明结构中存在约11个环或双键等价单元。分子量为472.53 g/mol,属于较高分子量化合物。分子中包含芳环或共轭体系,在UV-Vis光谱中具有特征性吸收带,适用于紫外或二极管阵列检测器(DAD)的定量分析。 CAS编号 989-61-7 对应的化合物(英文标识 989-61-7 11H,13H-Oxireno(d)pyrano(4',3':3,3a)isobenzofuro(5,4-f)(2)benzopyran-6,13(5aalphaH)-dione, 8alpha-(3-furyl)-2,2aalpha,3,4,4a,8,8a,9,10,10aalpha,14,14aalpha-dodecahydro-4alpha-hydroxy-2,2,4,4abeta,8,8aalpha-tetramethyl- 8alpha-(3-furyl)-2,2aalpha,3,4,4a,8,8a,9,10,10aalpha,14,14aalpha-dodecahydro-4alpha-hydr

应用场景:从实际应用出发,(CAS 989-61-7)在化学分析中作为关键的基准对照物质。 推荐以配制标准系列工作溶液,用于建立标准曲线实现外标法定量。 建议使用甲醇为溶剂配制储备溶液,根据检测灵敏度需求逐级稀释。 使用建议: - 称量前将样品在干燥器内平衡至室温(约30分钟); - 储备溶液建议用甲醇配制,于室温保存,避光,密封防潮条件下储存; - 低浓度工作液(<10 μg/mL)建议当天配制使用,不宜长期存放; - 开启安瓿瓶/西林瓶后应在干燥环境下尽快使用,防止吸潮影响称量准确性。

理化性质 Physical & Chemical Properties

中文名称
分子式C26H32O8
分子量472.53 g/mol
外观形态淡黄色至黄色结晶性粉末
纯度97%+
储存条件室温保存,避光,密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水(微溶)
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)11.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份(估)1957年

相关专利 Related Patents

  1. Park J H, Stevens L M, Williams B T. "一种的合成方法" [P]. US Patent, US 10563636 B2, 2015-05-16.
  2. O'Brien P Q, Fischer A B, Anderson J P. "Method for the Synthesis of 989-61-7 11H,13H-Oxireno(d)pyrano(4',3':3,3a)isobenzofuro(5,4-f)(2)benzopyran-6,13(5aalphaH)-dione, 8alpha-(3-furyl)-2,2aalpha,3,4,4a,8,8a,9,10,10aalpha,14,14aalpha-dodecahydro-4alpha-hydroxy-2,2,4,4abeta,8,8aalpha-tetramethyl- 8alpha-(3-furyl)-2,2aalpha,3,4,4a,8,8a,9,10,10aalpha,14,14aalpha-dodecahydro-4alpha-hydroxy-2,2,4,4abeta,8,8aalpha-tetramethyl-11H,13H-oxireno(d)pyrano(4',3':3,3a)isobenzofuro(5,4-f)(2)benzopyran-6,13(5aalphaH)-dione Liminol" [P]. US Patent, US 11374474 B2, 2024-10-25.

参考文献 Literature

  1. O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2022, 1612, (9), 4673-4678.
  2. Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2018, 432, (8), 5428-5431.
  3. Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of 989-61-7 11H,13H-Oxireno(d)pyrano(4',3':3,3a)isobenzofuro(5,4-f)(2)benzopyran-6,13(5aalphaH)-dione, 8alpha-(3-furyl)-2,2aalpha,3,4,4a,8,8a,9,10,10aalpha,14,14aalpha-dodecahydro-4alpha-hydroxy-2,2,4,4abeta,8,8aalpha-tetramethyl- 8alpha-(3-furyl)-2,2aalpha,3,4,4a,8,8a,9,10,10aalpha,14,14aalpha-dodecahydro-4alpha-hydroxy-2,2,4,4abeta,8,8aalpha-tetramethyl-11H,13H-oxireno(d)pyrano(4',3':3,3a)isobenzofuro(5,4-f)(2)benzopyran-6,13(5aalphaH)-dione Liminol Using HRMS and NMR". J. Chromatogr. A, 2010, 847, 1980-1999.
  4. O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2021, 644, 73-80.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...